(Q35966831)

English

Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

6

object named as

Alan W Partin

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

H Ballentine Carter

7

object named as

H Ballentine Carter

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Patricia K. Landis

5

object named as

Patricia Landis

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Jonathan I. Epstein

3

object named as

Jonathan I Epstein

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

author name string

Danil V Makarov

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Cameron Marlow

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

M Craig Miller

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Robert W Veltri

8

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

publication date

1 February 2008

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

68

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

183-189

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Cancer statistics, 2006

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

Delayed versus immediate surgical intervention and prostate cancer outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

Expectant treatment with curative intent in the prostate-specific antigen era: triggers for definitive therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

How to judge a tumor marker

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

p300 modulates nuclear morphology in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

Update on watchful waiting for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

The complex genetic epidemiology of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

Evaluation of proprostate specific antigen for early detection of prostate cancer in men with a total prostate specific antigen range of 4.0 to 10.0 ng/ml

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

Pathological and molecular aspects of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

Expectant management of nonpalpable prostate cancer with curative intent: preliminary results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

Quantitative nuclear grade (QNG): a new image analysis-based biomarker of clinically relevant nuclear structure alterations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

Contemporary use of complexed PSA and calculated percent free PSA for early detection of prostate cancer: impact of changing disease demographics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

Nuclear structure-gene expression interrelationships: implications for aberrant gene expression in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

Analysis of repeated biopsy results within 1 year after a noncancer diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

Prostate specific antigen: a decade of discovery--what we have learned and where we are going

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

Nuclear texture: can it be used as a surrogate endpoint biomarker?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

Further observations on the chemistry of Pararosaniline-Feulgen staining

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

2 October 2017

Prostate cancer: indicators of aggressiveness.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

11 July 2018

Prospective evaluation of men with stage T1C adenocarcinoma of the prostate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

11 July 2018

Identification of nuclear matrix proteins in the cancer and normal rat prostate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

11 July 2018

Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

11 July 2018

Global histone modification patterns predict risk of prostate cancer recurrence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

24 September 2018

Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

24 September 2018

Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy: epidemiologic significance of annual changes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

24 September 2018

An algorithm for predicting nonorgan confined prostate cancer using the results obtained from sextant core biopsies with prostate specific antigen level.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354531

24 September 2018

Inadequacies of the current American Joint Committee on cancer staging system for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18085616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate-specific antigen and other serum markers: current concepts from the World Health Organization Second International Consultation on Prostate Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18085616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Judging New Markers by Their Ability to Improve Predictive Accuracy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18085616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18085616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18085616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ability to predict metastasis based on pathology findings and alterations in nuclear structure of normal-appearing and cancer peripheral zone epithelium in the prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/18085616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18085616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18085616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standardization of the Feulgen-Schiff technique. Staining characteristics of pure fuchsin dyes; a cytophotometric investigation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18085616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18085616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Computer-generated diagnosis and image analysis. An overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/18085616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18085616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative nuclear morphometry, Markovian texture descriptors, and DNA content captured on a CAS-200 Image analysis system, combined with PCNA and HER-2/neu immunohistochemistry for prediction of prostate cancer progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18085616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of clinically nonpalpable prostate-specific antigen-detected (cT1c) versus palpable (cT2) prostate cancers in patients undergoing radical retropubic prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18085616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/PROS.20679

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35966831&oldid=1980513618"